SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bruce Rosen who wrote (2568)2/27/1998 9:49:00 AM
From: Tokyo VD   of 7041
 
Bruce,

Although you have chosen to spotlight the December 1997 article that Robert Whitaker penned on Zonagen, you have failed to mention that he also authored a very POSITIVE article in June 1997, titled "Zonagen: A Model for CRO-SMO Collaboration".

The positive selectivity in that article was out of context and debatable interpretations with regard to the chronology of events made me wonder if he had a position in Zonagen?

When I read the Zonagen article in June, I was struck by how similar it was to the Volpe and Raymond James reports. What is amazing to me is the time of the stock offering everyone was repeating the same story. Amazing.

Tokyo
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext